Not applicableNo Longer AvailableNCT03642691
What this trial is testing
A Treatment Protocol for Expanded Access Administration of Prometic Plasminogen Due to Closure of Clinical Trial
Who this might be right for
Hypoplasminogenemia
Prometic Biotherapeutics, Inc.